Browsing Tag
Soligenix
3 posts
SGX945 demonstrates lasting oral ulcer reduction in Phase 2 Behçet’s disease trial
Find out how SGX945 achieved durable oral ulcer reduction in a phase 2 Behçet’s disease trial published in Rheumatology (Oxford).
Soligenix announces promising results in extended HyBryte treatment study for cutaneous T-cell lymphoma
Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company, has shared an interim update on a key study involving…
Soligenix all set to begin FLASH clinical trial for SGX301 in CTCL
US biopharma company Soligenix has wrapped up enrolling patients for its phase 3 Fluorescent Light Activated Synthetic Hypericin…